研究者業績

山下 武志

Takeshi Yamashita

基本情報

所属
自治医科大学 附属さいたま医療センター総合診療科/医学部総合医学第1講座 助教
学位
医学博士(岩手医科大学)

通称等の別名
Takeshi Yamashita
J-GLOBAL ID
201401071322911460
researchmap会員ID
B000238087

学歴

 2

論文

 18
  • Michiko Matsuzawa Adachi, Katsuyuki Yoshida, Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara
    Annals of Internal Medicine: Clinical Cases 3(8) 2024年8月1日  
  • Fukuko Matsumoto, Michiko Matsuzawa Adachi, Katsuyuki Yoshida, Takeshi Yamashita, Jun Shiihara, Takahiko Fukuchi, Haruka Morikawa, Masahiko Hiruta, Keisuke Tanno, Noriko Oyama-Manabe, Hisashi Oshiro, Hitoshi Sugawara
    Internal Medicine 2024年7月  査読有り
  • Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara, Yoshiro Okajima, Masahiro Hiruta
    Cureus 16(3) e55749 2024年3月7日  査読有り筆頭著者
    Anorexia nervosa (AN) is often accompanied by numerous medical complications and mental disorders. There are few specialized AN facilities in Japan, resulting in the unmet medical needs of patients with AN. A 37-year-old Japanese woman was admitted to the hospital after experiencing a disturbance of consciousness. Her body mass index was 10.2 kg/m2. She developed the following serious medical concomitants associated with extremely severe AN: hypothermia, shock liver, refractory hypoglycemia, acute gastric mucosal bleeding, gelatinous marrow transformation, catheter-related bloodstream infection and infective endocarditis due to β-lactamase-negative Staphylococcus aureus, aspiration pneumonia, intracranial hemorrhage, candidemia, and osmotic demyelination syndrome in the pons, which led to a fatal condition that quickly worsened after we started treatment. The patient was able to overcome several serious concomitants and be discharged from the hospital after multidisciplinary treatment team care. AN is associated with increased rates of all-cause mortality. It is important to take an interdisciplinary approach with emergency physicians, intensivists, hematologists, gastroenterologists, psychiatrists, clinical psychologists, a nutrition support team with a nationally registered nutritionist and hospitalists, and hospitalization as required based on appropriate medical evaluation with good patient and family rapport. Furthermore, social and educational efforts aimed at preventing the development of AN are necessary.
  • Takeshi Yamashita, Takahiko Fukuchi, Hitoshi Sugawara
    Journal of general and family medicine 2022年11月7日  査読有り筆頭著者
    A 37year old Japanese man experienced severe sore throat. He was infected by the Omicron variant of SARSCoV2. The posterior pharyngeal wall in the left showed closely aggregated multiple milletsized white spots with surrounding redness.
  • 上田 洲裕, 柴田 頌太, 堤内 路子, 眞山 英徳, 山下 武志, 田中 享, 崎山 快夫
    臨床神経学 62(8) 671-671 2022年8月  
  • Tamami Watanabe, Takeshi Yamashita, Hitoshi Sugawara
    Internal Medicine 61(10) 1629-1629 2022年5月15日  
  • Naoko Yukihira, Hiroshi Hori, Takeshi Yamashita, Ai Kawamura, Takahiko Fukuchi, Hitoshi Sugawara
    Internal Medicine 60(10) 1621-1625 2021年5月15日  
    Aggregatibacter actinomycetemcomitans, an etiological agent associated with periodontitis, endocarditis, and other infections, has rarely been implicated in spondylitis. A 70-year-old man with aortic valve replacement presented with a 4-month history of lower back pain and was diagnosed with spondylitis. Prolonged incubation of blood cultures and a biopsy yielded A. actinomycetemcomitans. Concurrent infective endocarditis (IE) was probable considering the infectious organism and the patients' prosthetic valve. The patient was treated with ceftriaxone and recovered well. Pyogenic spondylitis with possible concurrent IE may be caused by A. actinomycetemcomitans. Extended incubation and repeated cultures should be considered if Haemophilus spp., Aggregatibacter spp, Cardiobacterium spp, Eikenella spp, and Kingella spp. (HACEK) infection is suspected.
  • Tamami Watanabe, Takeshi Yamashita, Hitoshi Sugawara, Takahiko Fukuchi, Akira Ishii, Yoshiaki Nagai, Fumiyoshi Ohyanagi, Shinichiro Koyama, Junko Ushijima, Kenjiro Takagi, Akira Tanaka
    Internal medicine (Tokyo, Japan) 58(7) 991-997 2019年4月1日  
  • Nozomu Yoshino, Ai Kawamura, Akira Ishii, Katsuyuki Yoshida, Tamami Watanabe, Takeshi Yamashita, Takahiko Fukuchi, Fumihiko Toyoda, Akihiko Kakehashi, Hitoshi Sugawara
    Internal Medicine 57(11) 1661-1665 2018年6月1日  
  • Shuji Hatakeyama, Takeshi Yamashita, Toshiyasu Sakai, Katsuhiko Kamei
    The American journal of tropical medicine and hygiene 97(1) 38-41 2017年7月  
    Talaromyces marneffei is a dimorphic fungus endemic mainly in southeast and south Asia. It causes severe mycosis, usually in immunocompromised individuals, such as those with human immunodeficiency virus (HIV) infection. Concomitant infection with T. marneffei and other opportunistic pathogens is plausible because the majority of T. marneffei infections occur in patients with advanced HIV infection. Nonetheless, coinfection in the same site has rarely been reported, and poses a considerable diagnostic and therapeutic challenge. We report the case of an HIV-infected Japanese patient who had lived in Thailand for 6 years. The patient developed T. marneffei and Mycobacterium tuberculosis coinfection, and both pathogens were isolated from the same sites: a blood specimen and a lymph node aspirate. Clinicians should be aware of concomitant infection with T. marneffei and other pathogens in patients with advanced HIV disease who are living in or who have visited endemic areas.
  • Hitoshi Sugawara, Katsuhiko Matsuura, Akira Ishii, Takeshi Yamashita
    Journal of general and family medicine 18(2) 88-89 2017年4月  
  • Eri Watanabe, Hitoshi Sugawara, Takeshi Yamashita, Akira Ishii, Aya Oda, Chihiro Terai
    Case reports in medicine 2016 5656320-5656320 2016年  
    We report the case of a 71-year-old Japanese woman with adult-onset Still's disease (AOSD) in whom macrophage activation syndrome (MAS) developed despite therapy with oral high-dose prednisolone and intravenous methylprednisolone pulse therapy twice. She was successfully treated with tocilizumab (TCZ). Soon afterward, her fever ceased and high levels of both ferritin and C-reactive protein levels decreased. Her course was complicated by disseminated intravascular coagulation, cytomegalovirus infection, and Pneumocystis jirovecii pneumonia. After these were resolved, AOSD-associated MAS was well controlled. She was discharged on hospital day 87. Although biologics such as TCZ are becoming established for the treatment of AOSD, there is no recommended therapy for AOSD-associated MAS. Several biologics have been tried for this complication, but their efficacy and safety remain controversial. We reviewed reported cases of AOSD-associated MAS successfully treated with various biologics. TCZ initiation after adequate nonselective immunosuppressive therapy, such as methylprednisolone pulse therapy or a prednisolone-based combination of immunosuppressants, can be an effective treatment for AOSD-associated MAS. On the other hand, biologics given after insufficient immunosuppressive therapy may cause MAS. A strategy combining adequate immunosuppression and a biologic could be safe if special attention is given to adverse events such as opportunistic infections or biologic-associated MAS.
  • Michito Namekawa, Takeshi Yamashita, Yoshio Sakiyama
    Internal Medicine 55(8) 1033-1033 2016年  
  • Takeshi Yamashita, Masashi Yoshida, Hodaka Yamada, Tomoko Asano, Atsushi Aoki, Aki Ikoma, Ikuyo Kusaka, Masafumi Kakei, San-e Ishikawa
    INTERNAL MEDICINE 53(8) 845-849 2014年  査読有り筆頭著者
  • Masakazu Kobayashi, Kuniaki Ogasawara, Taro Suzuki, Hiroki Kuroda, Takeshi Yamashita, Kenji Yoshida, Yoshitaka Kubo, Akira Ogawa
    NEUROLOGIA MEDICO-CHIRURGICA 52(3) 161-164 2012年3月  査読有り
  • Takeshi Yamashita, Kuniaki Ogasawara, Hiroki Kuroda, Taro Suzuki, Kohei Chida, Masakazu Kobayashi, Kenji Yoshida, Yoshitaka Kubo, Akira Ogawa
    CLINICAL NUCLEAR MEDICINE 37(2) 128-133 2012年2月  査読有り筆頭著者
  • Yasushi Ogasawara, Kuniaki Ogasawara, Taro Suzuki, Takeshi Yamashita, Hiroki Kuroda, Kohei Chida, Shunrou Fujiwara, Kenta Aso, Masakazu Kobayashi, Kenji Yoshida, Kazunori Terasaki, Akira Ogawa
    American journal of nuclear medicine and molecular imaging 2(1) 77-87 2012年  
    PURPOSE: Cerebral hyperperfusion following carotid endarterectomy (CEA) occurs in patients with preoperative impairments in cerebral hemodynamics. The aim of the present study was to determine whether late images/early images on preoperative brain (123)I-iomazenil (IMZ) single-photon emission computed tomography (SPECT), which correlate with oxygen extraction fraction images on positron emission tomography, could identify patients at risk for cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery (ICA) stenosis. METHODS: In 80 patients, preoperative brain SPECT scans were initiated immediately after (early images) and 180 min after (late images) administration of (123)I-IMZ. A region of interest (ROI) was automatically placed in the middle cerebral artery territory in both the cerebral hemispheres using a three-dimensional stereotaxic ROI template. Transcranial regional cerebral oxygen saturation (rSO(2)) was monitored using near-infrared spectroscope throughout carotid endarterectomy, and a patient was defined as having cerebral hyperperfusion when a ratio of rSO(2) at the end of the surgery to rSO(2) before ICA clamping was ≥ 1.1. RESULTS: Cerebral hyperperfusion was observed on intraoperative rSO(2) monitoring in eight patients (10%). Preoperative increase in affected side-to-contralateral side asymmetry on late/early (123)I-IMZ value was the only significant independent predictor of cerebral hyperperfusion (95% confidence interval [CI], 1.606 to 8.710; P = 0.0010). The preoperative late/early (123)I-IMZ asymmetry corresponded to an 88% sensitivity and 89% specificity, with 47% positive- and 98% negative-predictive values for the development of cerebral hyperperfusion. CONCLUSIONS: Preoperative late/early (123)I-IMZ images can identify patients at risk for cerebral hyperperfusion following endarterectomy for unilateral cervical ICA stenosis.
  • Hiroaki Saura, Kuniaki Ogasawara, Taro Suzuki, Hiroki Kuroda, Takeshi Yamashita, Masakazu Kobayashi, Kazunori Terasaki, Akira Ogawa
    CEREBROVASCULAR DISEASES 33(4) 354-361 2012年  査読有り

MISC

 41

書籍等出版物

 1

講演・口頭発表等

 10